210
Views
26
CrossRef citations to date
0
Altmetric
Review

Recent advances of TNF-α antagonists in rheumatoid arthritis and chronic heart failure

, &
Pages 617-625 | Published online: 03 May 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Giuliano Tocci, Delia Goletti, Valentina Marino, Andrea Matucci, Giuseppe Maria Milano, Fabrizio Cantini & Raffaele Scarpa. (2016) Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis. Expert Opinion on Drug Safety 15:sup1, pages 55-61.
Read now
Giampiero Girolomoni, Gianfranco Altomare, Fabio Ayala, Enzo Berardesca, Piergiacomo Calzavara Pinton, Sergio Chimenti, Patrizia Martini, Andrea Peserico, Antonio Puglisi Guerra & Gino Antonio Vena. (2015) Differential management of mild-to-severe psoriasis with biologic drugs: An Italian Delphi consensus expert panel. Journal of Dermatological Treatment 26:2, pages 128-133.
Read now

Articles from other publishers (24)

Chien-Chung Yang, Li-Der Hsiao, Ya-Fang Shih, Mei-Hsiu Su & Chuen-Mao Yang. (2022) Sphingosine 1-Phosphate-Upregulated COX-2/PGE2 System Contributes to Human Cardiac Fibroblast Apoptosis: Involvement of MMP-9-Dependent Transactivation of EGFR Cascade. Oxidative Medicine and Cellular Longevity 2022, pages 1-22.
Crossref
Rodolfo H.V. Nishimura, Artur de L.L. Vaz, Leandro A. Bozzini, Valter E. Murie & Giuliano C. Clososki. (2019) Recent applications of magnesium- and Zinc-TMP amides in the synthesis of bioactive targets. Tetrahedron 75:4, pages 464-474.
Crossref
S. Könemann, M. Dörr & S.B. Felix. 2017. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases 681 714 .
Elías Forero, Monique Chalem, Gloria Vásquez, Edwin Jauregui, Luis Fernando Medina, Luis Fernando Pinto Peñaranda, John Medina, Yimy Medina, Diego Jaimes, Ana Milena Arbelaez, Aura María Domínguez, Andrés Fernández, Oscar Jair Felipe-Díaz, Philippe Chalem, Carlo Vinicio Caballero Uribe, María José Jannaut, Ixhel García, Wilson Bautista, Javier Ramírez Figueroa, Jorge Cortés, Jorge Quintero & Nohora Rodríguez. (2016) Risk management for prescribing biological therapies. Revista Colombiana de Reumatología (English Edition) 23:1, pages 50-67.
Crossref
Elías Forero, Monique Chalem, Gloria Vásquez, Edwin Jauregui, Luis Fernando Medina, Luis Fernando Pinto Peñaranda, John Medina, Yimy Medina, Diego Jaimes, Ana Milena Arbelaez, Aura María Domínguez, Andrés Fernández, Oscar Jair Felipe-Díaz, Philippe Chalem, Carlo Vinicio Caballero Uribe, María José Jannaut, Ixhel García, Wilson Bautista, Javier Ramírez Figueroa, Jorge Cortés, Jorge Quintero & Nohora Rodríguez. (2016) Gestión de riesgo para la prescripción de terapias biológicas. Revista Colombiana de Reumatología 23:1, pages 50-67.
Crossref
Songnian Lin, Sunita Malkani, Matthew Lombardo, Lihu Yang, Sander G. Mills, Kevin Chapman, James E. Thompson, Wen Xiao Zhang, Ruixiu Wang, Rose M. Cubbon, Edward A. O’Neill & Jeffrey J. Hale. (2015) Design, synthesis, and biological evaluation of aminopyrazine derivatives as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). Bioorganic & Medicinal Chemistry Letters 25:22, pages 5402-5408.
Crossref
Dong Xiao, Xiaohong Zhu, Michael Sofolarides, Sylvia Degrado, Ning Shao, Ashwin Rao, Xiao Chen, Robert Aslanian, James Fossetta, Fang Tian, Prashant Trivedi, Daniel Lundell & Anandan Palani. (2014) Discovery of a novel series of potent MK2 non-ATP competitive inhibitors using 1,2-substituted azoles as cis-amide isosteres. Bioorganic & Medicinal Chemistry Letters 24:15, pages 3609-3613.
Crossref
Dong Xiao, Anandan Palani, Xianhai Huang, Michael Sofolarides, Wei Zhou, Xiao Chen, Robert Aslanian, Zhuyan Guo, James Fossetta, Fang Tian, Prashant Trivedi, Peter Spacciapoli, Charles E. Whitehurst & Daniel Lundell. (2013) Conformation constraint of anilides enabling the discovery of tricyclic lactams as potent MK2 non-ATP competitive inhibitors. Bioorganic & Medicinal Chemistry Letters 23:11, pages 3262-3266.
Crossref
Nai Lee Lui, Julian Thumboo & Robert Inman. (2011) Cardiomyopathy in ankylosing spondylitis. Arthritis Care & Research 63:4, pages 564-569.
Crossref
Ronni Wolf, Jasna Lipozenčić & Batya B. Davidovici. 2011. Emergency Dermatology. Emergency Dermatology 168 177 .
Hanrui Zhang, Brandon MorganBarry J. Potter, Lixin MaKevin C. Dellsperger, Zoltan Ungvari & Cuihua Zhang. (2010) Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging. American Journal of Physiology-Heart and Circulatory Physiology 299:4, pages H985-H994.
Crossref
Juraj Velcicky, Roland Feifel, Stuart Hawtin, Richard Heng, Christine Huppertz, Guido Koch, Markus Kroemer, Henrik Moebitz, Laszlo Revesz, Clemens Scheufler & Achim Schlapbach. (2010) Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy. Bioorganic & Medicinal Chemistry Letters 20:3, pages 1293-1297.
Crossref
YT Zhao, L Shao, LL Teng, B Hu, Y Luo, X Yu, DF Zhang & H Zhang. (2009) Effects of n -3 Polyunsaturated Fatty Acid Therapy on Plasma Inflammatory Markers and N-Terminal Pro-brain Natriuretic Peptide in Elderly Patients with Chronic Heart Failure . Journal of International Medical Research 37:6, pages 1831-1841.
Crossref
Louis Vaickus, Sudha Natarajan, Jiyoun Kim & Daniel Remick. 2009. Emerging Protein Biotherapeutics. Emerging Protein Biotherapeutics.
Kelly M. Loyet, Rong Deng, Wei-Ching Liang, Yan Wu, Henry B. Lowman & Laura E. DeForge. (2009) Technology comparisons for anti-therapeutic antibody and neutralizing antibody assays in the context of an anti-TNF pharmacokinetic study. Journal of Immunological Methods 345:1-2, pages 17-28.
Crossref
Songnian Lin, Matthew Lombardo, Sunita Malkani, Jeffrey J. Hale, Sander G. Mills, Kevin Chapman, James E. Thompson, Wen Xiao Zhang, Ruixiu Wang, Rose M. Cubbon, Edward A. O?Neill, Silvi Luell, Ester Carballo-Jane & Lihu Yang. (2009) Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). Bioorganic & Medicinal Chemistry Letters 19:12, pages 3238-3242.
Crossref
Maria C BunielKatie Geelan-HansenPeter C WeberVincent K Tuohy. (2009) Immunosuppressive therapy for autoimmune inner ear disease. Immunotherapy 1:3, pages 425-434.
Crossref
Lei Yao, Guo-Ping Chen, Xian Lu, Liang-Rong Zheng, Yun Mou & Shen-Jiang Hu. (2008) Effects of atorvastatin on calcium-regulating proteins: a possible mechanism to repair cardiac dysfunction in spontaneously hypertensive rats. Basic Research in Cardiology 104:3, pages 258-268.
Crossref
Rainer SchulzGerd Heusch. (2009) Tumor Necrosis Factor-α and Its Receptors 1 and 2. Circulation 119:10, pages 1355-1357.
Crossref
Achim Schlapbach, Roland Feifel, Stuart Hawtin, Richard Heng, Guido Koch, Henrik Moebitz, Laszlo Revesz, Clemens Scheufler, Juraj Velcicky, Rudolf Waelchli & Christine Huppertz. (2008) Pyrrolo-pyrimidones: A novel class of MK2 inhibitors with potent cellular activity. Bioorganic & Medicinal Chemistry Letters 18:23, pages 6142-6146.
Crossref
Adrian Whitty. 2008. Gene Family Targeted Molecular Design. Gene Family Targeted Molecular Design 199 233 .
X-M Wang, M Hamza, SM Gordon, SM Wahl & RA Dionne. (2008) COX Inhibitors Downregulate PDE4D Expression in a Clinical Model of Inflammatory Pain. Clinical Pharmacology & Therapeutics 84:1, pages 39-42.
Crossref
Karen Sliwa & Aftab A Ansari. (2008) Immunosuppression as therapy for congestive heart failure. The Lancet 371:9608, pages 184-186.
Crossref
Tina Ding & Chris Deighton. (2007) Complications of anti-TNF therapies. Future Rheumatology 2:6, pages 587-597.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.